Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.670
+0.050 (3.09%)
At close: Dec 5, 2025, 4:00 PM EST
1.650
-0.020 (-1.20%)
After-hours: Dec 5, 2025, 7:06 PM EST
Ovid Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Ovid Therapeutics stock ranges from a low of $2.00 to a high of $5.00. The average analyst price target of $3.60 forecasts a 115.57% increase in the stock price over the next year.
Price Target: $3.60 (+115.57%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ovid Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $2 | Strong Buy | Maintains | $1.5 → $2 | +19.76% | Nov 24, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $5 | Buy | Initiates | $5 | +199.40% | Nov 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $1.5 | Strong Buy | Maintains | $2 → $1.5 | -10.18% | May 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +19.76% | Mar 24, 2025 |
| BTIG | BTIG | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +139.52% | Mar 24, 2025 |
Financial Forecast
Revenue This Year
6.67M
from 566.00K
Increased by 1,077.56%
Revenue Next Year
170.48K
from 6.67M
Decreased by -97.44%
EPS This Year
-0.50
from -0.37
EPS Next Year
-0.47
from -0.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.9M | 735,000 | ||||
| Avg | 6.7M | 170,483 | ||||
| Low | 6.4M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1,126.3% | -89.0% | ||||
| Avg | 1,077.6% | -97.4% | ||||
| Low | 1,025.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.41 | -0.26 | ||||
| Avg | -0.50 | -0.47 | ||||
| Low | -0.59 | -0.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.